Third Quarter 2026 Financial Summary
- Revenue:
$9.1 million , up 25% year over year, nine-month revenue$32.6 million , up 57% year over year, 100% organic and entirely quantum. - Operating Loss: GAAP operating loss was
$34.5 million , compared with$6.7 million in Q3 2025. Non-GAAP operating loss was$22.7 million , compared with$5.9 million in Q3 2025. - Cash Flow: Net cash used in operations of
$16.3 million and capital expenditures of$5.2 million . - Balance Sheet: At quarter end, cash, cash equivalents, and available-for-sale securities totaled
$560 million , with no debt. This balance included a$28 million temporary working-capital benefit from payroll taxes collected from stock-option exercises.
“We are building
Third Quarter and Recent Business Highlights
- Met 2026 Target of 30 Logical Qubits:
Infleqtion demonstrated 30 entangled logical qubits working together in a single computation on Sqale using 80 physical qubits. An AI-assisted discovery cut the physical gates needed for a key logical operation in half, reducing opportunities for errors as the Company works toward longer computations and 100 logical qubits in 2028. - Quantum Computers Operational in
Japan and theU.K .: Infleqtion’s QPU powers Japan’s first operational full-stack neutral atom quantum computer under the country's Moonshot program, joining Infleqtion’s deployed system at theU.K .'s National Quantum Computing Centre. - Expanded Computing Collaborations and Customer Application Work:
Infleqtion announced collaborations with NVIDIA, Cisco and Riverlane to advance quantum networking, error correction and software integration, capabilities needed to scale quantum computers and support more demanding customer applications.Infleqtion also launched itsQuantum Application Forum series inLondon , bringing together companies from financial services, energy, pharmaceuticals and other industries to explore quantum computing applications. $20 Million NASA Expansion Contract Funds Next Stage ofQuantum Gravity Development :Infleqtion is developing quantum gravity sensing hardware with theJet Propulsion Laboratory for NASA’s Quantum Gravity Gradiometer Pathfinder program, bringing the cumulative value of Infleqtion’s contract to$40 million .$12 Million Award Funds Deployable Quantum Spectrum System: The award funds engineering and validation of Infleqtion’s Quantum Spectrum system for a direction-finding application, which detects radio signals and determines their direction. Initial development targets defense platforms where conventional antenna size limits deployment, bringing direction-finding capabilities to smaller systems.- Tiqker Demonstrates Rugged Operation in
U.S. Navy Exercises: Tiqker demonstrated sustained operation aboard RV Merlin under demanding maritime conditions. The demonstration supports future naval integration of GPS-independent precision timing for navigation, communications and other mission-critical systems.
Conference Call Details
The Company will host a conference call at
Live Call
Domestic Dial-In: 1-877-869-3847
International Dial-In: 1-201-689-8261
Replay
Domestic Dial-In: 1-877-660-6853
International Dial-In: 1-201-612-7415
Access ID: 13763444
Webcast
Event URL: https://event.webcasts.com/starthere.jsp?ei=1779772&tp_key=8d863a1477
The replay will be available approximately three hours after the conclusion of the conference call through
Upcoming Speaking and Event Participation
- November 15–20: Supercomputing,
Chicago, IL November 24 : Piper Sandler Virtual Quantum Day- November 30–December 3: NVIDIA GTC DC,
Washington D.C. December 2 :UBS Technology Conference ,Scottsdale, AZ - December 7–11:
Australian Institute of Physics Congress 2026,Sydney, Australia - December 8–10: Q2B,
Chicago, IL December 16 : Craig-Hallum Quantum Event, virtual
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of federal securities laws, including the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, as amended. All statements contained in this press release that do not relate to matters of historical fact should be considered forward-looking, including statements regarding our financial condition, the Company’s expected 2026 revenue, business strategy and plans, business outlook, customer demand, commercial opportunities, and market momentum. These forward-looking statements generally are identified by the words “anticipate,” “believe,” “contemplate,” “continue,” “could,” “estimate,” “expect,” “forecast,” “future,” “intend,” “may,” “might,” “opportunity,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strategy,” “strive,” “target,” “will,” or “would,” the negative of these words or other similar terms or expressions. The absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on Infleqtion’s current expectations, assumptions and projections as of the date of this release and are subject to risks and uncertainties that could cause actual results to differ materially and adversely. Such risks and uncertainties include, without limitation, those related to Infleqtion’s ability to recognize anticipated benefits of its business combination with
Non-GAAP Financial Measures
This press release includes certain non-GAAP financial measures.
“Non-GAAP Cost of revenue” is defined as cost of revenue expense adjusted to exclude, when applicable, stock-based compensation.
“Non-GAAP R&D” is defined as research and development expense adjusted to exclude, when applicable, stock-based compensation.
“Non-GAAP SG&A” is defined as selling, general and administrative expense adjusted to exclude, when applicable, stock-based compensation, acquisition and integration costs, go-public transaction expenses and former executive release payment.
“Non-GAAP Loss from operations” is defined as loss from operations adjusted to exclude, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, former executive release payment and impairment of assets and goodwill.
“Non-GAAP Net loss” is defined as net loss adjusted to exclude, when applicable, stock-based compensation, go-public transaction expenses, acquisition and integration costs, unrealized gain or loss on equity investment, change in fair value of contingent consideration, change in fair value of SAFE liabilities, former executive release payment and impairment of assets and goodwill.
See “Reconciliation of Non-GAAP Financial Measures” in this press release for reconciliations of these non-GAAP measures to the most directly comparable GAAP measures. Management believes that Non-GAAP Cost of revenue, Non-GAAP R&D, Non-GAAP SG&A, Non-GAAP Loss from operations and Non-GAAP Net loss provide useful information to investors because they facilitate an evaluation of Infleqtion’s underlying operating performance and period-to-period comparability by excluding certain items that management believes do not directly reflect the Company’s core operations or may not be indicative of recurring operating results. Management uses these non-GAAP measures, together with the corresponding GAAP measures, to assess the operating performance of the business.
About
| |||||||||||||||
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Total revenue | $ | 9,149 |
|
| $ | 7,311 |
|
| $ | 32,594 |
|
| $ | 20,783 |
|
Total cost of revenue |
| 10,270 |
|
|
| 3,611 |
|
|
| 29,013 |
|
|
| 12,862 |
|
Gross profit (loss) |
| (1,121 | ) |
|
| 3,700 |
|
|
| 3,581 |
|
|
| 7,921 |
|
Research and development |
| 11,486 |
|
|
| 4,846 |
|
|
| 34,112 |
|
|
| 15,324 |
|
Selling, general and administrative |
| 22,031 |
|
|
| 5,989 |
|
|
| 68,169 |
|
|
| 18,023 |
|
Grant income |
| (159 | ) |
|
| (436 | ) |
|
| (1,332 | ) |
|
| (1,531 | ) |
Loss from operations |
| (34,479 | ) |
|
| (6,699 | ) |
|
| (97,368 | ) |
|
| (23,895 | ) |
Other income (expense): |
|
|
|
|
|
|
| ||||||||
Unrealized gain on equity investment |
| 9,742 |
|
|
| — |
|
|
| 9,742 |
|
|
| — |
|
Interest income |
| 5,289 |
|
|
| 780 |
|
|
| 13,512 |
|
|
| 1,855 |
|
Other, net |
| (231 | ) |
|
| (274 | ) |
|
| 21 |
|
|
| 842 |
|
Total other income, net |
| 14,800 |
|
|
| 506 |
|
|
| 23,275 |
|
|
| 2,697 |
|
Loss before income taxes |
| (19,679 | ) |
|
| (6,193 | ) |
|
| (74,093 | ) |
|
| (21,198 | ) |
Income tax expense (benefit) |
| — |
|
|
| — |
|
|
| — |
|
|
| — |
|
Net loss | $ | (19,679 | ) |
| $ | (6,193 | ) |
| $ | (74,093 | ) |
| $ | (21,198 | ) |
Other comprehensive income (loss): |
|
|
|
|
|
|
| ||||||||
Unrealized gain (loss) on available-for-sale securities, net |
| (1,019 | ) |
|
| 105 |
|
|
| (2,096 | ) |
|
| 105 |
|
Foreign currency translation |
| (83 | ) |
|
| (204 | ) |
|
| (323 | ) |
|
| 190 |
|
Total other comprehensive income (loss) |
| (1,102 | ) |
|
| (99 | ) |
|
| (2,419 | ) |
|
| 295 |
|
Comprehensive loss | $ | (20,781 | ) |
| $ | (6,292 | ) |
| $ | (76,512 | ) |
| $ | (20,903 | ) |
Net loss per share attributable to common stockholders - basic and diluted | $ | (0.09 | ) |
| $ | (0.38 | ) |
| $ | (0.39 | ) |
| $ | (1.34 | ) |
Weighted average shares used in computing net loss per share attributable to common stockholders – basic and diluted |
| 225,169,501 |
|
|
| 16,369,143 |
|
|
| 188,061,219 |
|
|
| 15,791,879 |
|
| |||||||
| As of | ||||||
| September |
|
| ||||
Assets |
|
|
| ||||
Current Assets: |
|
|
| ||||
Cash and cash equivalents | $ | 51,890 |
|
| $ | 11,694 |
|
Available-for-sale securities, current |
| 426,825 |
|
|
| 34,318 |
|
Accounts receivable |
| 8,421 |
|
|
| 9,543 |
|
Unbilled receivables |
| 4,336 |
|
|
| 2,637 |
|
Inventories |
| 7,786 |
|
|
| 4,299 |
|
Prepaid expenses and other current assets |
| 7,722 |
|
|
| 10,036 |
|
Total current assets | $ | 506,980 |
|
| $ | 72,527 |
|
Property and equipment, net |
| 12,792 |
|
|
| 8,674 |
|
Operating lease right-of-use assets |
| 15,573 |
|
|
| 4,923 |
|
Available-for-sale securities, non-current |
| 81,307 |
|
|
| 17,157 |
|
| 9,315 |
|
|
| 9,315 |
| |
Other assets |
| 14,440 |
|
|
| 620 |
|
Total Assets | $ | 640,407 |
|
| $ | 113,216 |
|
Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit) |
|
|
| ||||
Current Liabilities: |
|
|
| ||||
Accounts payable | $ | 5,139 |
|
| $ | 5,644 |
|
Accrued liabilities |
| 45,413 |
|
|
| 8,923 |
|
Contract liabilities |
| 7,504 |
|
|
| 6,871 |
|
Current portion of operating lease liabilities |
| 501 |
|
|
| 1,076 |
|
Deferred consideration payable, current |
| — |
|
|
| 471 |
|
Total current liabilities | $ | 58,557 |
|
| $ | 22,985 |
|
Operating lease liabilities, net of current portion |
| 16,411 |
|
|
| 4,074 |
|
Deferred consideration payable |
| — |
|
|
| — |
|
Total Liabilities | $ | 74,968 |
|
| $ | 27,059 |
|
Convertible Redeemable Preferred Stock: |
|
|
| ||||
Series Seed convertible redeemable preferred stock; |
| — |
|
|
| 6,526 |
|
Series Seed II convertible redeemable preferred stock; |
| — |
|
|
| 10,411 |
|
Series A convertible redeemable preferred stock; |
| — |
|
|
| 36,658 |
|
Series B convertible redeemable preferred stock; |
| — |
|
|
| 112,145 |
|
Series B-1 convertible redeemable preferred stock; |
| — |
|
|
| 32,990 |
|
Series C convertible redeemable preferred stock; |
| — |
|
|
| 71,733 |
|
Series C-1 convertible redeemable preferred stock; |
| — |
|
|
| 26,351 |
|
Total Convertible Redeemable Preferred Stock | $ | — |
|
| $ | 296,814 |
|
Stockholders’ Equity (Deficit): |
|
|
| ||||
Preferred stock: |
| — |
|
|
| — |
|
Common stock: |
| 23 |
|
|
| 2 |
|
Additional paid-in capital |
| 874,518 |
|
|
| 21,931 |
|
Accumulated deficit |
| (307,589 | ) |
|
| (233,496 | ) |
Accumulated other comprehensive income (loss) |
| (1,513 | ) |
|
| 906 |
|
Total Stockholders' Equity (Deficit) | $ | 565,439 |
|
| $ | (210,657 | ) |
Total Liabilities, Convertible Redeemable Preferred Stock and Stockholders’ Equity (Deficit) | $ | 640,407 |
|
| $ | 113,216 |
|
| |||||||
| Nine Months Ended | ||||||
|
| 2026 |
|
|
| 2025 |
|
Cash flows from operating activities |
|
|
| ||||
Net loss | $ | (74,093 | ) |
| $ | (21,198 | ) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
| ||||
Depreciation and amortization expense |
| 3,024 |
|
|
| 2,410 |
|
Stock-based compensation expense |
| 31,296 |
|
|
| 2,660 |
|
Change in fair value of contingent obligation |
| 1,508 |
|
|
| — |
|
Unrealized gain on equity investment |
| (9,742 | ) |
|
| — |
|
Amortization of premiums and accretion of discounts on available-for-sale securities |
| (3,376 | ) |
|
| — |
|
Other non-cash operating adjustments |
| 176 |
|
|
| 110 |
|
Changes in operating assets and liabilities: |
|
|
| ||||
Accounts receivable |
| 1,091 |
|
|
| (399 | ) |
Unbilled receivables |
| (1,713 | ) |
|
| 660 |
|
Inventories |
| (3,487 | ) |
|
| (1,832 | ) |
Prepaid expenses and other current assets |
| (2,865 | ) |
|
| 812 |
|
Other assets |
| (165 | ) |
|
| (12 | ) |
Accounts payable |
| (475 | ) |
|
| 1,971 |
|
Accrued liabilities |
| 35,000 |
|
|
| (404 | ) |
Contract liabilities |
| 641 |
|
|
| (335 | ) |
Operating lease right-of-use assets |
| 1,327 |
|
|
| 490 |
|
Operating lease liabilities |
| (460 | ) |
|
| (877 | ) |
Net cash used in operating activities |
| (22,313 | ) |
|
| (15,944 | ) |
Cash flows from investing activities |
|
|
| ||||
Purchases of available-for-sale securities |
| (620,067 | ) |
|
| (51,415 | ) |
Maturities of available-for-sale securities |
| 164,600 |
|
|
| — |
|
Purchase of non-marketable equity investment |
| (3,000 | ) |
|
| — |
|
Purchases of property and equipment |
| (6,899 | ) |
|
| (1,212 | ) |
Net cash used in investing activities |
| (465,366 | ) |
|
| (52,627 | ) |
Cash flows from financing activities |
|
|
| ||||
Proceeds from issuance of Series C convertible redeemable preferred stock |
| — |
|
|
| 49,225 |
|
Proceeds from stock options and warrant exercises |
| 5,321 |
|
|
| 826 |
|
Proceeds from stockholder contribution |
| 300 |
|
|
| — |
|
Payment of accrued issuance costs |
| — |
|
|
| (2,410 | ) |
Payment of offering costs |
| (4,092 | ) |
|
| (1,021 | ) |
Proceeds from Business Combination, net of redemptions |
| 528,166 |
|
|
| — |
|
Payment of deferred cash consideration |
| (475 | ) |
|
| (1,425 | ) |
Net cash provided by financing activities |
| 529,220 |
|
|
| 45,195 |
|
Foreign currency translation |
| (411 | ) |
|
| 323 |
|
Net increase (decrease) in cash and cash equivalents and restricted cash | $ | 41,130 |
|
| $ | (23,053 | ) |
Cash, cash equivalents and restricted cash at beginning of period | $ | 11,894 |
|
| $ | 48,142 |
|
Cash, cash equivalents and restricted cash at end of period | $ | 53,024 |
|
| $ | 25,089 |
|
| |||||||||||
The following is a reconciliation of non-GAAP measures of | |||||||||||
| Three Months Ended |
| Nine Months Ended | ||||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||
Cost of revenue | $ | 10,270 |
| $ | 3,611 |
| $ | 29,013 |
| $ | 12,862 |
Adjustments: |
|
|
|
|
|
|
| ||||
Stock-based compensation |
| 2,166 |
|
| 66 |
|
| 5,004 |
|
| 267 |
Non-GAAP Cost of revenue | $ | 8,104 |
| $ | 3,545 |
| $ | 24,009 |
| $ | 12,595 |
| Three Months Ended |
| Nine Months Ended | ||||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||
Research and development expense | $ | 11,486 |
| $ | 4,846 |
| $ | 34,112 |
| $ | 15,324 |
Adjustments: |
|
|
|
|
|
|
| ||||
Stock-based compensation |
| 1,653 |
|
| 96 |
|
| 8,887 |
|
| 284 |
Non-GAAP R&D | $ | 9,833 |
| $ | 4,750 |
| $ | 25,225 |
| $ | 15,040 |
| Three Months Ended |
| Nine Months Ended | ||||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||
Selling, general and administrative expense | $ | 22,031 |
| $ | 5,989 |
| $ | 68,169 |
| $ | 18,023 |
Adjustments: |
|
|
|
|
|
|
| ||||
Stock-based compensation |
| 7,118 |
|
| 611 |
|
| 17,405 |
|
| 2,109 |
Acquisition and integration costs |
| 874 |
|
| — |
|
| 2,346 |
|
| 2,000 |
Go-public transaction expenses |
| — |
|
| — |
|
| 11,466 |
|
| — |
Former executive release payment |
| — |
|
| — |
|
| 750 |
|
| — |
Non-GAAP SG&A | $ | 14,039 |
| $ | 5,378 |
| $ | 36,202 |
| $ | 13,914 |
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Loss from operations | $ | (34,479 | ) |
| $ | (6,699 | ) |
| $ | (97,368 | ) |
| $ | (23,895 | ) |
Adjustments: |
|
|
|
|
|
|
| ||||||||
Stock-based compensation |
| 10,937 |
|
|
| 773 |
|
|
| 31,296 |
|
|
| 2,660 |
|
Acquisition and integration costs |
| 874 |
|
|
| — |
|
|
| 2,346 |
|
|
| 2,000 |
|
Go-public transaction expenses |
| — |
|
|
| — |
|
|
| 11,466 |
|
|
| — |
|
Former executive release payment |
| — |
|
|
| — |
|
|
| 750 |
|
|
| — |
|
Non-GAAP Loss from operations | $ | (22,668 | ) |
| $ | (5,926 | ) |
| $ | (51,510 | ) |
| $ | (19,235 | ) |
| Three Months Ended |
| Nine Months Ended | ||||||||||||
|
| 2026 |
|
|
| 2025 |
|
|
| 2026 |
|
|
| 2025 |
|
Net loss | $ | (19,679 | ) |
| $ | (6,193 | ) |
| $ | (74,093 | ) |
| $ | (21,198 | ) |
Adjustments: |
|
|
|
|
|
|
| ||||||||
Stock-based compensation |
| 10,937 |
|
|
| 773 |
|
|
| 31,296 |
|
|
| 2,660 |
|
Acquisition and integration costs |
| 874 |
|
|
| — |
|
|
| 2,346 |
|
|
| 2,000 |
|
Go-public transaction expenses |
| — |
|
|
| — |
|
|
| 11,466 |
|
|
| — |
|
Unrealized gain on equity investment 1 |
| (9,742 | ) |
|
| — |
|
|
| (9,742 | ) |
|
| — |
|
Former executive release payment |
| — |
|
|
| — |
|
|
| 750 |
|
|
| — |
|
Non-GAAP Net loss | $ | (17,610 | ) |
| $ | (5,420 | ) |
| $ | (37,977 | ) |
| $ | (16,538 | ) |
Note 1 - Represents the increase in the carrying value of the Company’s investment in a privately held company resulting from an observable price change during the period. | |||||||||||||||
View source version on businesswire.com: https://www.businesswire.com/news/home/20261116153109/en/
Investor Contact
investors@infleqtion.com
Media Contact
Emily O’Brien
media@infleqtion.com
Source: